Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EUR | -0.81% | -2.38% | +2.07% |
04-22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
04-11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- Press Releases